Literature DB >> 25332581

Aberrant Immunophenotypic Expression of CD5 in a Case of B Acute Lymphoblastic Leukemia: A Case Report.

Deepti Mutreja1, Hara Prasad Pati1, Divya Bansal1, Rahul Kumar Sharma1, Sonal Jain1.   

Abstract

Aberrant expression of CD5 has rarely been reported in B cell lineage acute lymphoblastic leukemia (B-ALL). We report the rare immunophenotypic expression of CD5 in a 20-year-old male who was diagnosed to have B-ALL on bone marrow examination. Cytogenetic analysis revealed a mosaic supernumerary marker chromosome. The patient died due to acute pancreatitis after admission. CD5 positive B-ALL may represent a distinct clinicopathologic subcategory of B-ALL with an aggressive clinical course.

Entities:  

Year:  2014        PMID： 25332581      PMCID： PMC4192253          DOI： 10.1007/s12288-014-0332-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  9 in total

1.  Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.

Authors:  Adam C Seegmiller; Steven H Kroft; Nitin J Karandikar; Robert W McKenna
Journal:  Am J Clin Pathol       Date:  2009-12       Impact factor: 2.493

2.  Brief report. CD19/CD5 acute lymphoblastic leukemia.

Authors:  D Subirá; A Roman; C Jiménez-Garófano; E Prieto; B Martínez-Delgado; E Aceituno; R García; J Outeiriño
Journal:  Med Pediatr Oncol       Date:  1998-12

3.  Aberrant T-cell antigen expression in B lymphoblastic leukaemia.

Authors:  Shafinaz Hussein; Kamraan Z Gill; Anthony N Sireci; Adriana I Colovai; Tania Small; Foxwell N Emmons; Vundavalli V Murty; Govind Bhagat; Bachir Alobeid
Journal:  Br J Haematol       Date:  2011-09-19       Impact factor: 6.998

Review 4.  Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration.

Authors:  Angela Ogden; Padmashree C G Rida; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

5.  CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma.

Authors:  Dragan Jevremovic; Roxana S Dronca; William G Morice; Ellen D McPhail; Paul J Kurtin; Clive S Zent; Curtis A Hanson
Journal:  Leuk Res       Date:  2010-04-01       Impact factor: 3.156

6.  CD5-positive B-cell acute lymphoblastic leukemia.

Authors:  Michael R Peterson; Kyle J Noskoviak; Robert Newbury
Journal:  Pediatr Dev Pathol       Date:  2007 Jan-Feb

7.  CD5-positive acute lymphoblastic leukemia.

Authors:  Dawood Ahmed; Tahir Aziz Ahmed; Suhaib Ahmed; Hamid Nawaz Tipu; Muhammad Amin Wiqar
Journal:  J Coll Physicians Surg Pak       Date:  2008-05       Impact factor: 0.711

8.  Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production.

Authors:  Hélène Gary-Gouy; Julie Harriague; Georges Bismuth; Cornelia Platzer; Christian Schmitt; Ali H Dalloul
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

Review 9.  A systematic analysis of small supernumerary marker chromosomes using array CGH exposes unexpected complexity.

Authors:  Kavita S Reddy; Swaroop Aradhya; Jeanne Meck; George Tiller; Sridevi Abboy; Harold Bass
Journal:  Genet Med       Date:  2012-08-30       Impact factor: 8.822
  9 in total
  2 in total

1.  CD5 Positive B Lymphoblastic Leukemia: Report of a Case with Review of Literature.

Authors:  Sreejesh Sreedharanunni; Narender Kumar; Alka Khadwal
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-04       Impact factor: 0.900

2.  Precursor B-lineage acute lymphoblastic leukemia patients with aberrant natural killer cell and T cell - lineage antigen expression: experience from a tertiary cancer care center.

Authors:  Karthik Bommannan; Jhansi Rani Arumugam; Venkatraman Radhakrishnan; Jayachandran Perumal Kalaiyarasi; Nikita Mehra; Tenali Gnana Sagar; Shirley Sundersingh
Journal:  Hematol Transfus Cell Ther       Date:  2020-10-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.